• Practical Guide: HyperScribe™ T7 High Yield Cy3 RNA Labeling

  2026-08-03

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus addresses the need for reliable, high-yield synthesis of randomly Cy3-labeled RNA probes for sensitive fluorescence-based detection in research applications such as in situ hybridization and Northern blotting. It should not be used for diagnostic, therapeutic, or clinical workflows, and is strictly limited to research purposes.

• Dual-Metric In Vitro Assessment Refines Cancer Drug Evaluati

  2026-08-03

  Schwartz’s dissertation introduces a dual-metric approach to in vitro drug response evaluation in cancer, distinguishing between proliferative arrest and cell death. This nuanced analysis reveals that most anticancer agents impact both processes in distinct ways, enabling more precise characterization of therapeutic efficacy and mechanism.

• SNS-032 (BMS-387032): Deep Mechanistic Insights in Cancer an

  2026-08-02

  Explore the advanced mechanisms and unique applications of SNS-032 (BMS-387032), a selective cyclin-dependent kinase inhibitor pivotal in cancer and host-targeted antiviral research. This in-depth analysis highlights novel translational insights and practical protocol guidance.

• Z-VAD-FMK: Advanced Caspase Inhibition in Viral Immunity Res

  2026-08-01

  Explore the unique role of Z-VAD-FMK in dissecting apoptosis and necroptosis crosstalk within viral immunity research. This article offers new experimental insights, building on recent findings, for scientists leveraging this pan-caspase inhibitor in immune and infection models.

• SB203580: Precision Inhibition of p38 MAPK in Disease Models

  2026-07-31

  SB203580, a selective p38 MAPK inhibitor, empowers researchers to dissect inflammatory and stress signaling with reproducible precision. By leveraging its ATP-competitive binding and high specificity, scientists can unravel the mechanistic underpinnings of diseases like COPD and neuroinflammation, while overcoming common experimental pitfalls.

• Nebivolol Hydrochloride in β1-Adrenoceptor Signaling Researc

  2026-07-31

  Nebivolol hydrochloride stands apart as a highly selective β1-adrenoceptor antagonist, delivering robust specificity for cardiovascular and signaling pathway studies. This article dissects the latest workflow optimizations, interprets new cross-pathway findings, and provides actionable troubleshooting tips for advanced translational research.

• FH1: Advancing Hepatocyte Maturation for Translational Innov

  2026-07-30

  This thought-leadership article explores the transformative role of FH1 (Catalog No. B3700) in driving functional maturation of iPS cell-derived hepatocytes (iHeps), offering mechanistic insights, protocol guidance, and strategic context for translational researchers. By connecting FH1-enabled hepatic models with new frontiers in regulated gene therapy, it articulates a vision for next-generation liver disease modeling and cell-based therapy design.

• (-)-Arctigenin: Precision MEK1 Inhibition in Tumor Immunolog

  2026-07-30

  Explore how (-)-Arctigenin, a next-generation MEK1 inhibitor, delivers mechanistic and translational leverage for researchers targeting the tumor microenvironment, with a focus on breast cancer progression and NF-κB pathway modulation. This article bridges cutting-edge clinical insights, protocol guidance, and strategic positioning—demonstrating how APExBIO’s Arctigenin sets new standards for reliability and innovation in oncology research.

• Maraviroc (UK-427857): Applied Workflows in CCR5-Driven Dise

  2026-07-29

  Maraviroc (UK-427857) extends far beyond HIV-1 entry inhibition, enabling precise dissection of CCR5-mediated signaling in both immunovirology and inflammatory disease models. This article delivers actionable guidance and troubleshooting for researchers harnessing Maraviroc in workflows ranging from RA extracellular vesicle modulation to neuroinflammation and beyond.

• Indometacin Sodium: Translational Gateways in Inflammation R

  2026-07-29

  Explore how Indomethacin Sodium Trihydrate, a powerful nonsteroidal anti-inflammatory drug (NSAID), enables breakthrough strategies in translational inflammation research. This article bridges mechanistic insight with actionable guidance, contextualizing its role in anti-inflammatory, neuroregenerative, and pain pathway studies. Discover evidence-based protocol parameters, competitive positioning, and a forward-looking outlook for innovators.

• PFHxS-Induced Hepatotoxicity via PPARα in Zebrafish Larvae

  2026-07-28

  This study demonstrates that perfluorohexanesulfonic acid (PFHxS), a prevalent short-chain PFAS, triggers significant hepatotoxicity in larval zebrafish through activation of the PPARα signaling pathway. By integrating transcriptomic profiling with functional assays and PPARα antagonism, the authors establish a mechanistic link between environmental PFHxS exposure and impaired liver development, highlighting new directions for metabolic disease and environmental toxicology research.

• S Tag Peptide (A6007): Technical Guide for Fusion Tag Workfl

  2026-07-28

  S Tag Peptide addresses persistent challenges in recombinant protein workflows by improving solubility and enabling reliable antibody-based detection and purification. It is best suited for applications requiring enhanced solubility and affinity-based detection of fusion proteins, but should not be used where ethanol solubility or autonomous enzymatic activity is required.

• Ibrexafungerp (MK 3118): Applied Antifungal Workflows & Trou

  2026-07-27

  Ibrexafungerp (MK 3118) empowers researchers to tackle multidrug-resistant Candida, offering robust efficacy in challenging environments like acidic pH. This guide details evidence-driven protocols, workflow optimizations, and troubleshooting strategies for in vitro and in vivo antifungal research.

• Isradipine (Dynacirc): Precision Tools for Calcium Channel R

  2026-07-27

  Explore how Isradipine (Dynacirc) enables next-generation studies of L-type calcium channels, with a unique focus on translational neuroprotection and rigorous assay design. Distinct from existing content, this article synthesizes advanced mechanistic insights and protocol strategies.

• IPR-803: Disrupting Tumor Microenvironment and Stromal Barri

  2026-07-26

  Explore how IPR-803, a potent urokinase receptor inhibitor, uniquely targets the tumor microenvironment to inhibit metastasis and enhance drug delivery. This in-depth analysis reveals advanced applications, mechanistic insights, and practical protocols for cancer research.

16791 records 1/1120 page Next 12345 下5页 Last page